
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded troche containing pregnenolone, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing pregnenolone is listed. Products containing it are filed in the directory as homeopathic products, in liquid and spray forms. None of the listed products containing pregnenolone is in troche form.
Bases for this dose form differ, and the base used decides how USP <795> classifies the preparation for beyond-use dating. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Pregnenolone is a naturally occurring steroid precursor with no FDA-approved drug product; a pharmacy may compound it when a prescriber orders it.
Pregnenolone is a steroid the body makes from cholesterol. Inside cell mitochondria, the cytochrome P450 side-chain cleavage enzyme converts cholesterol to pregnenolone, which enzymes can then convert to the neurosteroid pregnenolone sulfate. An FDA-funded University of Maryland review reports that pregnenolone is not available as an FDA-approved product and is sold in the United States as an oral and sublingual dietary supplement. FDA's list of bulk drug substances nominated for 503A compounding places pregnenolone in Category 1, substances under evaluation. A prescriber might order it compounded when a patient needs a form or strength not available as a supplement. Compounded preparations are not FDA-approved and require a prescription.
Because there is no FDA-approved pregnenolone product, there is no FDA label with boxed warnings, contraindications, drug interactions, or pregnancy and breastfeeding guidance. The University of Maryland review found that the three clinical experts it interviewed did not use, prescribe or recommend pregnenolone. Pregnenolone is a steroid the body makes from cholesterol, so tell your prescriber about any hormone therapy, other steroid-related supplements, and all other medicines and supplements you take. If you are pregnant, planning a pregnancy or breastfeeding, talk with your prescriber before using it. Report any new or unusual symptoms. Talk to your prescriber or pharmacist about side effects and whether pregnenolone is appropriate for you.
Pregnenolone is formed when P450scc cleaves the cholesterol side chain in the mitochondrial matrix; sulfotransferases then convert it to pregnenolone sulfate, a neurosteroid studied as a modulator of synaptic plasticity. Smith and colleagues review preclinical and clinical work on pregnenolone and pregnenolone sulfate for cognitive dysfunction in schizophrenia. The University of Maryland M-CERSI review, done for a 503B nomination, found 19 studies; schizophrenia was the most common indication, with others including bipolar depression, mood and cognition, hypercholesterolemia, pain and rheumatoid arthritis. These are not FDA-approved indications, and no FDA-approved product exists. For 503A compounding, a bulk substance must meet a USP or NF monograph, be a component of an FDA-approved drug, or appear on the 503A bulks list; FDA's interim policy lists pregnenolone in Category 1, under evaluation. Dosing is per prescriber. Use a bulk source with a valid certificate of analysis from an FDA-registered establishment, as FDA's 503A page requires.
Wash and dry your hands. Place the troche between your cheek and gum or under your tongue, as your label directs, and let it dissolve. Do not chew or swallow it whole unless told to. Dissolving can take up to 30 minutes. Follow your label about eating or drinking around the dose.
Troches are nonaqueous, so a USP <795> default beyond-use date of up to 180 days usually applies. Store in the closed container in a cool, dry place at room temperature, away from heat so they do not soften, and out of reach of children. Discard after the beyond-use date on the label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place 1 troche between cheek and gum and let slowly dissolve